Breaking News!

Iykeman Online News

By Chidilue…

New FDA approved Molecule for treatment of Endometrial Cancer “Dorstalimab”, What you should know.

The United States of America foremost drug regulator FDA today gave an accelerated approval to the immunotherapy molecule dostarlimab branded as (Jemperli) for the treatment of recurrent or advanced endometrial cancer with deficient mismatch repair (dMMR). What you should know. Dortalimab is an inhibitor and its usage is limited to patients who have progressed on orContinue reading “New FDA approved Molecule for treatment of Endometrial Cancer “Dorstalimab”, What you should know.”


Follow Our Blog

Get new content delivered directly to your inbox.